Return to Listing

2 result(s) for Thyroid

PI Name Protocol # Title
Kresimira Milas IRB00009420 Oregon Index of Endocrine Neoplasias (ORION)
Matthew Taylor IRB00009480 A Randomized, Double Blind Study to Compare the Complete Remission Rate Following a 5-Week Course of Selumetinib or Placebo and Single Dose Adjuvant Radioactive Iodine Therapy in Patients with Differentiated Thyroid Cancer
 

You may also qualify for Phase 1 Program trials.

 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080